48results about How to "Confirm effect" patented technology

An image pickup apparatus that can easily perform electric fine zoom adjustment, includes an image pickup section that can change an image pickup parameter, a display section that visibly displays an image signal outputted from the image pickup section, a rotational operation member that performs a change operation to the image pickup parameter, a parameter control section that controls the image pickup parameter, and a display control section that displays an effect of the change of the image pickup parameter in accordance with the rotational operation of the rotational operation member on the display section, while superimposing the effect on the image signal outputted from the image pickup section.

A first video signal having a first frame rate optionally settable is generated by an image pickup device, and the first video signal is memorized in a memory and outputted from the memory. A write control device controls the write of the first video signal with respect to the memory, and a read control device controls the read of the video signal with respect to the memory. The write control device writes respective first frame data constituting the first video signal in the memory in each cycle determined by the first frame rate of the first video signal. The read control device reads the first frame data as a second video signal. The second video signal is formed from sequentially arranging the first frame data in a partially duplicating manner in a standard video signal having a standard frame rate based on a determined arrangement rule. The predetermined arrangement rule is an arrangement rule employed when respective frame data constituting a video signal having a second frame rate equal to or lower than the standard frame rate are arranged in a duplicating manner in the standard video signal. In the foregoing manner, an time elongation / contraction effect on an image can be speedily and inexpensively obtained.

The present invention is related to powder or extracts of plant leaves with anti-obesity effects and anti-obesity food comprising them and more particularly, anti-obesity food compositions comprising powder or extracts of one or more selected from group consisting of persimmon leaves, buckwheat leaves, Chinese matrimony vine leaves, endive leaves, and a ginseng. The present invention is related to compositions comprising plant extracts or powder to reduce the weight of animals or human, and more particularly, boiling water extracts of persimmon leaves, buckwheat leaves and Chinese matrimony vine leaves and powder of persimmon leaves, buckwheat leaves and Chinese matrimony vine leaves were prepared and administered to animals or human to confirm effects of reduction of their weight and then health foods comprising the extracts or powder are produced wherein the healthy foods have very excellent effects on the reduction of weight of animals or human without side effects, thereby they have prominent effects on healthy food industry.

A substrate heating apparatus for heating a substrate coated with a film of chemically amplified resist within a period after exposure and before development, having a mounting table to mount the substrate substantially horizontal with the resist-coated film faced up, a fluid supply mechanism for supplying glycerin to the substrate, and a heating mechanism for heating the substrate on a mounting table, in a state that glycerin contacts a resist-coated film, wherein the substrate on a mounting table is heated, in a state that glycerin contacts the resist-coated film.

A method of color conversion includes preserving a 0% density for a particular color in the pre-conversion state to maintain a 0% density after conversion is provided via a translation table. Density gradation methods include a gradient value structure such that the highlight and shadow regions of the density are more finely represented in comparison to non-highlight and non-shadow regions. A further density correction method includes supplying an amount of energy to a non-image area when printing using a first color, wherein the amount of energy will not produce a dot in the non-image area upon application of a second color. A printer may employ one or more of the above methods in the form of a translation table or a density correction patch.

A cartridge for storing and dispensing viscous fluid materials providing excellent productivity and gas barrier properties and free from external appearance defects at the site of film wrapping. The inventive cartridge for viscous fluid materials has a plunger 3 inserted into the bottom portion of a cartridge body 2 fabricated using insert injection molding by integrally molding a cylindrical barrel portion 5 of a multilayer structure produced by laminating a gas barrier layer 8 including a metal thin layer 8a on the exterior periphery or interior periphery of a plastic layer 7, and a lid 6 covering the top of said cylindrical barrel portion.

Provided is a composition for treating nerve damage-related diseases. The composition includes a human umbilical cord blood-derived mesenchymal stem cell as an active ingredient. The mesenchymal stem cell isolated and incubated from the human umbilical cord blood migrates to an injured area to be differentiated into a nerve cell or a neuroglial cell at the time of in vivo transplantation. Thus, the mesenchymal stem cell and a composition including the same can be effectively used in cell replacement therapy and gene therapy for treating diseases caused by nerve damage including a stroke, Parkinson's disease, Alzheimer's disease, Pick's disease, Huntington's disease, amyotrophic lateral sclerosis, traumatic central nervous system disease and a spinal cord injury.

In a baking jig 1 for holding a ceramic honeycomb molding 3 having a large number of cells 31 juxtaposed with one another in an axial direction, an upper surface 21 coming into contact with the ceramic honeycomb molding 3 has a concavo-convex shape and one of the end faces 32 of the ceramic honeycomb molding 3 is supported by a large number of parallel convex portions 21. Recess portions 22 formed between the large number of convex portions 21 constitute ventilation passages 4 communicating with outside, and at least 30% of cells among cells 31 of the ceramic honeycomb molding 3 opening to the one end face 32 communicate with the ventilation passages 4 so that a decomposition gas occurring inside can be diffused from a bottom portion.

The object of the invention is to provide a structure which not only can be reduced in size but also can secure the durability of an endless belt (11) to be provided on a driven pulley (4b) and a pulley rotation support apparatus for supporting the driven pulley (4b). In the invention, as the above pulley rotation support apparatus, there is used a three-point-contact-type or four-point-contact-type radial ball bearing (14b). An offset quantity δ, which is an axial-direction distance between the center α of a radial load applied from the endless belt (11) to the driven pulley (4b) and the center position β of the radial ball bearing (14b), is set 40% or less of the pitch circle diameter of the radial ball bearing (14b). The radial clearance of this radial ball bearing (14b) is set 0.2% or less of the above pitch circle diameter.

A magnetization controlling element includes a ferromagnetic material layer, an exchange coupling adjustment layer, an antiferromagnetic material layer, an electrode layer, a magnetic field applying mechanism which applies a magnetic field to the antiferromagnetic material layer, and an electric field applying mechanism which applies an electric field to the antiferromagnetic material layer. The antiferromagnetic material layer contains an antiferromagnetic material or ferrimagnetic material having a magnetoelectric effect, the ferromagnetic material layer includes a perpendicular magnetization film having a magnetization component perpendicular to the film surface, the ferromagnetic material layer includes a ferromagnetic material layer that is magnetically connected, through exchange coupling, to the antiferromagnetic material layer. The exchange coupling adjustment layer has a function of adjusting exchange coupling between the ferromagnetic material layer and the antiferromagnetic material layer.

A preventive / therapeutic composition for free radical diseases, characterized by containing as an active ingredient at least one kind of a fullerene, a fullerene derivative, and a composite comprising a fullerene or fullerene derivative and an organic compound with which the fullerene or derivative has been modified or clathrated. The composition is reduced in side effects, has the high ability to eliminate free radicals in the body, and further has excellent preparation stability.

The invention provides an electron beam apparatus having: a rear plate having a plurality of electron-emitting devices each provided with a device electrode, and a plurality of wirings connected to the device electrodes; and a face plate being provided with an anode electrode, and being arranged in opposition to the rear plate so as to be irradiated with an electron emitted from the electron-emitting device, wherein the device electrode is electrically connected to the wiring through an additional electrode, and the additional electrode is formed from an electroconductive material of which phase transition from a solid phase directly into a vapor phase is caused at a temperature not lower than a melting point of the device electrode within an evacuated atmosphere.

An oxide sintered body comprising a bixbyite phase composed of In2O3 and an A3B5O12 phase (wherein A is one or more elements selected from the group consisting of Sc, Y, La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb and Lu, and B is one or more elements selected from the group consisting of Al and Ga).

A method of restarting a TSA apparatus includes, in the case where the TSA apparatus was stopped when or after when a temperature of a purge gas which flows out from a first adsorption column (5a) during a regeneration process became a peak temperature, in the first adsorption column (5a), closing an entrance valve, an exit valve, and an atmosphere-releasing valve; in a second adsorption column (5b) during an adsorption process, closing an entrance valve and an exit valve and opening an atmosphere-releasing valve so as to release a gas in the opposite direction to feed air flow, followed by closing the atmosphere-releasing valve; pressurizing, just before a restart, the second adsorption column (5b) with feed air to a pressure necessary for the adsorption process; and performing, after the restart, the regeneration process and the adsorption process continuously from the time point of stopping the TSA apparatus.

The present invention aims at providing a well unit to be used in fabricating an apparatus whereby movements of cells based on their own actions can be accurately and easily detected, in detecting the chemotaxis of cells due to a chemotactic factor or the inhibition of the chemotaxis of cells by an inhibitor.Accordingly, the present invention provides a well unit to be used in an apparatus for detecting chemotaxis of cells and separating cells characterized in that a plural number of wells, in which a liquid sample can be held in a resting state, are connected to each other via a channel, the channel is provided with a bank, and, in the upper part of the bank, barriers constituting one or more grooves having a width and / or a depth fit for the diameter or deformability of cells are provided or a plane is provided so as to give a gap having a depth fit for the diameter or deformability of cells between the plane and the glass substrate.

A pharmaceutical composition for promoting nerve injury restoration and a use thereof are disclosed. Each unit of the pharmaceutical composition contains 0.5 to 8 g of L-ornithine, 1 to 5 g of aspartic acid, 3 to 10 g of arginine and 3 to 10 g of vitamin B6. The pharmaceutical composition can significantly promote recovery of the spinal nerve function, and particularly has a good therapeutic effect on acute myelitis.

The present invention relates to novel cannabidiol quinone derivatives of formula (I) (I) wherein R is the carbon atom of a, linear or branched group, represented by: alkyl, aryl, alkenyl, alkynyl, acyl or alkoxycarbonyl groups; or wherein R is the nitrogen atom of a, linear or branched group represented by: alkylamine, arylamine, alkenylamine or alkynylamine groups. The invention also relates to the use of any of the compounds of formula (I) as medicamentsin therapy, particularly for treating diseases and conditions responsive to PPARg modulation due to their high PPARg agonistic effect lacking electrophilic (Nrf2 activation) and cytotoxic activities. This invention also provides pharmaceutical compositions comprising said compounds and method of treating diseases with said compounds.

The present invention relates to sigma-1 receptor ligands, to uses of sigma-1 receptor ligands in treating drug resistance, methods of using sigma-1 receptor ligands in regulating P-glycoprotein expression, methods of screening for compositions (e.g., agonists) that activate the sigma-1 receptor, regulate P-glycoprotein expression and / or have tolerance reducing activity.

An image processing device includes a point-image restoration processing unit 40 which receives a photographic image as input, and subjects the photographic image to a point-image restoration process based on point-image restoration information to generate a restored image, an area information output unit 45 which outputs area information relating to a specific area in the restored image where restoration strength of the point-image restoration process based on the point-image restoration information is equal to or greater than a threshold value, a display control unit 50 which receives the restored image and the area information as input and performs display control to highlight the specific area in the restored image based on the area information, and a display unit 55 which highlights at least the specific area based on the display control by the display control unit 50.

A method of manufacturing a solar cell including a silicon wafer is provided. In certain example instances, the method may include flattening fine roughness existing on a side face of a silicon block or a silicon stack used for manufacturing the silicon wafer for use in the solar cell.

A resin-impregnated porous filler having meso-pores, micro-pores, and macro-pores is obtained by inserting a coupling agent or an inorganic material between layers of a stratified clay mineral to prepare a crosslinked structure between the layers; making the stratified clay mineral three-dimensional; and impregnating the macro-pores with resin.

A turbine blade for industrial gas turbine is used which includes a blade substrate formed of a single-crystal heat-resistant alloy containing C: 0.06 to 0.08%, B: 0.016 to 0.035%, Hf: 0.2 to 0.3%, Cr: 6.9 to 7.3%, Mo: 0.7 to 1.0%, W: 7.0 to 9.0%, Re: 1.2 to 1.6%, Ta: 8.5 to 9.5%, Nb: 0.6 to 1.0%, Al: 4.9 to 5.2%, Co: 0.8 to 1.2%, and the remainder substantially consisting of Ni with reference to mass, and includes a diffusion barrier layer, a metal layer, a bond coat, and a top coat, these layers and coats being stacked in this order on a surface of the blade substrate, the metal layer having a thickness of 5 to 30 μm. Thus, the turbine blade can be provided which has a thermal barrier coating formed without loss of a function of the diffusion barrier layer.

A seamless tube producing method uses a piercing / rolling plug wherein piercing / rolling is performed with an inclined rotary piercing mill while the seamless tube piercing / rolling plug is used as a piercing tool. In one mode, a front part and a rear part of the split plug are held as an integral plug, the front part being made of low alloy steel, and oxide films are formed on surfaces of the front part and rear part. In a second mode, the front part and / or rear part are replaceable via a removable mounting wherein a mandrel bar holding the plug goes through the rear part, the mandrel bar being coupled with the front part. A thickness of the oxide film formed in the front part can be 200 μm or more and the oxide film of the front part can be thicker than the oxide film of the rear part.

The present invention relates to a method for the screening of a therapeutic agent for Charcot-Marie-Tooth disease (CMT) using induced pluripotent stem cells and motor neurons differentiated therefrom. Particularly, the present inventors prepared induced pluripotent stem cells from the human fibroblasts originated from CMT patient. When the motor neurons differentiated from the said induced pluripotent stem cells are used for the screening of a therapeutic agent for Charcot-Marie-Tooth disease, the pharmaceutical effect of the therapeutic agent candidates can be easily evaluated during the screening. In addition, by the method to prepare the induced pluripotent stem cells, autologous motor neurons which are usable for the screening of a patient-specific therapeutic agent and the patient-specific treatment can be prepared.

An object of the present invention is to provide a radioactive metal anti-cadherin antibody which is highly accumulated specifically in cancer tissue. Another object is to provide a cancer therapeutic agent having high anti-cancer effect and safety and a cancer diagnostic agent. The radioactive metal-labeled anti-cadherin antibody is obtained by binding a radioactive metallic element to an anti-cadherin antibody via a metal-chelating reagent.

The purpose of the present invention is, when treating circulatory disease such as acute myocardial infarction, to correct a reduction in myocardial contractility and thereby prevent arrhythmia and the like, as well as to reduce infarct size. Provided is a neurostimulation device having a stimulus application part configured so as to apply a stimulus to a cervical or thoracic vagus nerve portion in a human or an animal, and a stimulus regulation part configured so as to regulate the quantity of stimulus applied from the stimulus application part to the vagus nerve portion. The stimulus regulation part establishes a quantity of stimulus that is less than a value at which adverse effects would be produced, determines the heart rate and R wave interval of the human or animal, and controls the quantity of stimulus on the basis of these determinations.